BioCentury
ARTICLE | Financial News

Adamas raises $48 million in IPO

April 11, 2014 12:26 AM UTC

Adamas Pharmaceuticals Inc. (NASDAQ:ADMS) raised $48 million through the sale of 3 million shares at $16 in an IPO underwritten by Credit Suisse; Piper Jaffray; William Blair; and Needham. The price -- at the low end of Adamas' proposed $16-$18 range -- values the company at $262.9 million. Adamas was down $1.99 (12%) to $14.01 on its first day of trading Thursday. ...